Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Following a revaluation of the cash element of the notional investment held within the GSK 401K plan (The Plan), which is notionally held in GSK American Depositary Shares (ADSs), the Administrators of the Plan notified GlaxoSmithKline plc and the under-mentioned Persons on 9 June 2014 of the following increase in the notional allocation of ADSs on 6 June 2014 at a price of $53.70 per ADS:-
Director/PDMR
|
Number of ADSs |
Connected Person |
Number of ADSs |
||
Dr M Slaoui
|
- |
Dr K Slaoui |
4 |
||
|
|
|
|||
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
V A Whyte
Company Secretary
9 June 2014